CD34+ Stem Cell Therapy Improves mortality in refractory angina Dr. Thomas Povsic and Dr. C. Michael Gibson Discuss

Role of Evidence-Based Treatments in NSTEMI Outcome Dr. Karolina Szummer and Dr. C. Michael Gibson Discuss

Improvement of Outcomes for CV Emergencies in the US CV Emergencies in the United States

Silent MI: A Risk Factor for Heart Failure? Link between silent myocardial infarction and heart failure

In a recent analysis published in the Journal of the American College of Cardiology, a link between silent myocardial infarction and subsequent heart failure has been demonstrated, revealing a novel potential marker for heart failure. Continue reading

Mortality in PCI Patients With Incomplete Revascularization

In a recent retrospective observational study published in JAMA Cardiology, patients that underwent percutaneous coronary interventions with incomplete revascularization were at higher risk of mortality if they had at least 90% stenosis in an incompletely revascularized vessel, incomplete revascularization in 2 or more vessels, or proximal left anterior descending artery incomplete revascularization. Continue reading

Implementation of Evidence-Based Treatments in NSTEMI Outcomes

Dr. C. Michael Gibson discusses the trial findings with Dr. Karolina Szummer at AHA 2017

Opportunities to Improve Outcomes for CV Emergencies in the US

Ms. Mayme Roettig, Dr. James Jollis, Dr. Christopher Granger, Dr. Timothy Henry and Dr. C. Michael Gibson Discuss

Intersection of CAD and TAVR

Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

Effect of CER-001 on Coronary Atherosclerosis

Dr. Stephen J. Nicholls and Dr. Serge Korjian Discuss

Bleeding With Low-Dose Rivaroxaban Versus Aspirin After ACS

Dr. E. Magnus Ohman and Dr. Serge Korjian Discuss